The suppression was associated with a T cell–mediated immune response, revealing a haploid insufficient function of Bcl11b in immune modulation against lymphoma and offering an explanation for the complex relationship between Bcl11b status with T-ALL prognosis.29 In our recent study, we created mice with heterozygous BCL11B deletion. This evidence concerns the gene BCL11B and acute lymphoblastic leukemia.